Perci Health has closed a new £3m round, doubling its original £1.5m target.
This brings the total the virtual cancer clinic has raised to £7.7m funding.
This includes a £295,000 investment from Macmillan Cancer Support. Guinness Ventures and Conduit Fund have joined existing investors Octopus Ventures and 35 oncologists and cancer surgeons in backing Perci Health.
The new funds will support the company’s plans to expand its AI-powered, multidisciplinary virtual cancer clinic, reaching more individuals and healthcare providers across the UK.
Chantal Cox, investor at Octopus Ventures, said: “We’re incredibly impressed by the way Perci Health is tackling the gaps in cancer care with a human-first, tech-enabled model.
“This approach not only addresses pressing healthcare needs but also delivers measurable impact in terms of both clinical outcomes and cost-efficiency, which is vital for scaling the model across more insurers, employers, and health systems.”
Kelly McCabe, co-founder and CEO of Perci Health, (pictured left) added: “Our mission to close the cancer care gap is powered by an outstanding team who are deeply committed to transforming the cancer care experience.
“This investment will allow us to continue pioneering a model of care that integrates digital innovation with compassionate, specialist-led support, providing better outcomes for everyone living with and beyond cancer.”
Morgan Fitzsimons, co-founder and chief customer officer at Perci Health, said: “We know that cancer doesn’t stop when treatment ends.
“In fact, that’s often when people need the most support. Perci Health’s AI-driven platform ensures truly personalised care, enabling people to access the right support at the right time.”
Lisa Fox, head of co-investment at Guinness Ventures, said: “At Guinness Ventures, we look for founders who are solving meaningful problems in an innovative way.
“Perci Health is doing exactly that in addressing one of the biggest and most underserved challenges in cancer care: how we support people after treatment ends. Their model combines clinical rigour with scalable technology, delivering meaningful outcomes not just for patients, but also for employers, insurers, and the broader healthcare ecosystem.”
Eva-Maria Dimitriadis, managing partner at Conduit Fund, said: “Supporting businesses that are developing scalable, meaningful impact in healthcare is a priority for us.
“Perci Health’s innovative, patient-centric model, combined with its strong leadership and growth potential, is precisely the kind of forward-thinking solution that we want to help grow.
“As a female led business ourselves – with a majority female investment team – we know female founders statistically find it considerably more difficult to raise from VCs.
“We believe investing in female founders is not just the right thing to do, but it gives us access to exceptional opportunities that others overlook. 42% of companies we have invested in have at least one female founder and we are thrilled to add Perci Health to that list.”
Claire Taylor, chief nursing officer at Macmillan Cancer Support, said: “Cancer survivorship presents unique challenges, and we must innovate to meet the growing needs of people living with and beyond cancer.
“Perci Health’s holistic, multidisciplinary approach is exactly the exciting innovation that is needed, and it aligns perfectly with Macmillan’s ambitions to help more people get the personalised care they need.
“This partnership represents a shared commitment to making a real difference in the lives of those affected by cancer, helping people to live well and by providing tailored solutions to meet their changing needs following a cancer experience.”
